Nigel Killeen

Calcivis Ltd. provides dental assessment services. The firm offers preventive dentistry, CALCIVIS photoprotein, and CALCIVIS imaging devices. The company was founded by Adam Christie and Bruce Vernon in 2012 and is headquartered in Edinburgh, the United Kingdom.

SRI International provides contract research and development services. It is an independent, nonprofit research institute conducting client-sponsored research and development for government agencies, commercial businesses, foundations, and other organizations. The company was founded in 1946 and is headquartered in Menlo Park, CA.

VWR International LLC engages in the supply and distribution of laboratory equipment. It offers products in the areas of research and development, production, life science, healthcare, safety and industrial, controlled environment, furniture, chromatography, food and beverage analysis, and office supplies. The company was founded in 1852 and is headquartered in Radnor, PA.

miacom diagnostics GmbH develops and distributes rapid molecular diagnostic tests for the identification of pathogens directly from patient material. Its products include hemoFISH Gram, hemoFISH Masterpanel, hemoFISH S.aureus and CNS Screen, respiFISH HAP Gram Panel, respiFISH HAP Masterpanel, FISH Probes, Combined hotplate and hybridization chamber, 8-channel pipette, and fluorescence microscopes. The company was founded by Ian Thrippleton and Walter Freiherr von Stein in 2009 and is headquartered in Düsseldorf, Germany.

PhotoniCare, Inc. develops diagnostic tools. It offers ear imaging tool that uses light-based technology to see through the eardrum. The firm's product ClearView, the first product on the platform through which physicians manages middle ear infections. The company was founded by Ryan M. Nolan, Ryan L. Shelton and Stephen A. Boppart in 2013 and is headquartered in Champaign, IL.

Bluejay Mobile Health, Inc. is a full-service medical mobile technology and telehealth company. The company is headquartered in Livermore, CA.

Julz Pharma is an American company that specializes in fund raising, due diligence, drug/device development, and licensing or M & A negotiations. The company operates under standard legal terms and conditions and is headquartered in a hub for biotech activity. Julz Pharma identifies and solicits technology prior to the inflection point in the markets and leverages the experience and expertise of its management team in dealings with Chinese partners and market. The company's approach emphasizes innovation, science that stands apart from the pack, novel underlying therapeutic mechanisms, and significant potential for synergy with existing standards of care. Julz Pharma focuses on oncology therapeutics, autoimmune diseases, anti-infectives, cardiovascular diseases, and medical devices. The company has a structured risk mitigation approach, persuasive conceptual and mechanistic context preliminary data, and leadership of the in-licensed asset company. Julz Pharma's sound development strategy is essential on value, reimbursement guidance, and need potential for market penetration, proximity to clinical trials, and emphasis on co-development opportunities. The CEO of the company is Zishan Ahmad Haroon.